Results 201 to 210 of about 18,121,732 (293)
Editorial: Advances in DYRK1A syndrome: underlying mechanisms, disease models, and novel therapeutic approaches. [PDF]
Glass OK, Piton A, Pfalzer A.
europepmc +1 more source
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem cell marker in several malignancies. We established a novel epithelial cell line from rectal adenocarcinoma with unique overexpression of this enzyme. Genetic attenuation of ALDH1A1 led to increased invasive capacity and metastatic potential, the inhibition of proliferation activity, and ultimately ...
Martina Poturnajova +25 more
wiley +1 more source
Saving the split: An umbrella review on therapeutic approaches for cracked tooth syndrome. [PDF]
Kaur S +4 more
europepmc +1 more source
Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra +6 more
wiley +1 more source
Alopecia areata: from immunopathogenesis to emerging therapeutic approaches. [PDF]
Kim SY, Lee HJ, Heo J, Kim BJ, Seok J.
europepmc +1 more source
Tumors contain diverse cellular states whose behavior is shaped by context‐dependent gene coordination. By comparing gene–gene relationships across biological contexts, we identify adaptive transcriptional modules that reorganize into distinct vulnerability axes.
Brian Nelson +9 more
wiley +1 more source
The gut microbiome in graft-versus-host disease: mechanisms of immune modulation and therapeutic approaches. [PDF]
Moses AB, Yeh AC.
europepmc +1 more source

